4//SEC Filing
Spencer David M. 4
Accession 0001358403-18-000091
CIK 0001358403other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:02 PM ET
Size
8.7 KB
Accession
0001358403-18-000091
Insider Transaction Report
Form 4
Spencer David M.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2018-09-04$7.04/sh−10,000$70,413→ 89,939 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.95 to $7.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001627362
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:02 PM ET
- Size
- 8.7 KB